Philips gets FDA nod for next-gen reusable pulse oximetry clip sensor

Philips (NYSE:PHG) today announced that it received FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor.

The enhanced sensor incorporates internal optical refinements to further improve signal quality and measurement consistency. Amsterdam-based Philips says it supports reliable SpO₂ measurements across diverse patient populations and clinical conditions.

Pulse oximetry provides critical information to assess a patient’s oxygenation status. Philips says it takes a comprehensive approach to developing and evaluating sensor technologies to ensure signal quality in the face of a range of physiological, clinical and technical factors.

The company backed its reusable clip sensor with its pulse oximetry validation program. This evaluates performance across diverse patient populations, including varying skin tones and a range of physiological and clinical conditions.

Sign up for Blog Updates